BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14630509)

  • 1. Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging.
    Herschman HR; Talley JJ; DuBois R
    Mol Imaging Biol; 2003; 5(5):286-303. PubMed ID: 14630509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in inducible cyclooxygenase (COX-2) inhibition.
    de Leval X; Delarge J; Somers F; de Tullio P; Henrotin Y; Pirotte B; Dogné JM
    Curr Med Chem; 2000 Oct; 7(10):1041-62. PubMed ID: 10911017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
    Cronstein BN
    Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C
    J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever.
    Simmons DL; Wagner D; Westover K
    Clin Infect Dis; 2000 Oct; 31 Suppl 5():S211-8. PubMed ID: 11113025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
    Taketo MM
    J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation.
    Colville-Nash PR; Gilroy DW
    BioDrugs; 2001; 15(1):1-9. PubMed ID: 11437671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic pharmacological approach to the characterization of NSAIDs.
    Lora M; Denault JB; Leduc R; de Brum-Fernandes AJ
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):55-62. PubMed ID: 9758208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cyclooxygenases in inflammation, cancer, and development.
    Williams CS; Mann M; DuBois RN
    Oncogene; 1999 Dec; 18(55):7908-16. PubMed ID: 10630643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
    Kulkarni SK; Jain NK; Singh A
    Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):291-8. PubMed ID: 11031730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 and colon cancer: potential targets for chemoprevention.
    Fournier DB; Gordon GB
    J Cell Biochem Suppl; 2000; 34():97-102. PubMed ID: 10762021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and regulation of cyclooxygenase-2 during inflammation.
    Simon LS
    Am J Med; 1999 May; 106(5B):37S-42S. PubMed ID: 10390126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.
    Simmons DL; Botting RM; Hla T
    Pharmacol Rev; 2004 Sep; 56(3):387-437. PubMed ID: 15317910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2--10 years later.
    Hinz B; Brune K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):367-75. PubMed ID: 11805193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
    Gierse JK; Staten NR; Casperson GF; Koboldt CM; Trigg JS; Reitz BA; Pierce JL; Seibert K
    Vet Ther; 2002; 3(3):270-80. PubMed ID: 12447834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX in a crystal ball: current status and future promise of prostaglandin research.
    FitzGerald GA; Loll P
    J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs.
    Carabaza A; Cabré F; Rotllan E; Gómez M; Gutiérrez M; García ML; Mauleón D
    J Clin Pharmacol; 1996 Jun; 36(6):505-12. PubMed ID: 8809635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.